Medicalgorithmics S.A. (WSE:MDG)
27.00
0.00 (0.00%)
Jul 21, 2026, 5:00 PM CET
Medicalgorithmics Balance Sheet
Financials in millions PLN. Fiscal year is January - December.
Millions PLN. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 2.57 | 2.73 | 5.5 | 25.5 | 26.17 | 11.67 |
Cash & Short-Term Investments | 2.57 | 2.73 | 5.5 | 25.5 | 26.17 | 11.67 |
Cash Growth | -53.90% | -50.45% | -78.42% | -2.54% | 124.27% | -27.97% |
Accounts Receivable | 9.46 | 8.67 | 7.47 | 8.41 | 21.14 | 25.08 |
Inventory | 5.22 | 5.45 | 9.39 | 9.32 | 8.77 | - |
Total Current Assets | 17.25 | 16.85 | 22.37 | 43.23 | 56.08 | 36.75 |
Net Property, Plant & Equipment | 2.74 | 2.93 | 2.35 | 2.28 | 2 | 27 |
Other Intangible Assets | 90.52 | 87.31 | 78.47 | 72.7 | 63.92 | 50.57 |
Long-Term Investments | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.1 |
Other Long-Term Assets | 0.84 | 1.13 | 2.6 | 3.4 | - | - |
Total Assets | 111.36 | 108.23 | 105.81 | 121.63 | 122.02 | 114.41 |
Accounts Payable | 6.74 | 6.37 | 3.44 | 4.44 | 4.47 | 18.42 |
Accrued Expenses | 2.2 | 2.06 | 0.43 | - | - | - |
Short-Term Debt | 3.47 | 1.67 | 1.48 | - | - | - |
Other Current Liabilities | 3.1 | 2.88 | 3.62 | 3.39 | 5.14 | 1.63 |
Total Current Liabilities | 15.52 | 12.99 | 8.97 | 12.29 | 10.28 | 40.26 |
Long-Term Debt | 18.56 | 17.22 | 2.65 | 2.47 | 4.24 | 26.92 |
Other Long-Term Liabilities | 14.34 | 13.39 | 17.01 | 18.77 | 13.49 | 20.05 |
Total Long-Term Liabilities | 32.9 | 30.61 | 19.66 | 16.77 | 17.05 | 26.76 |
Total Liabilities | 48.42 | 43.6 | 28.63 | 29.07 | 27.34 | 67.02 |
Common Stock | 1 | 1 | 1 | 1 | 1 | 0.5 |
Additional Paid-in Capital | 211.77 | 211.7 | 211.41 | 210.98 | 210.98 | 148.12 |
Accumulated Other Comprehensive Income | -2.56 | -2.93 | -1.77 | -2.04 | -0.5 | 3.52 |
Retained Earnings | -147.29 | -145.14 | -133.46 | -117.38 | -116.8 | -104.76 |
Total Common Shareholders' Equity | 62.92 | 64.62 | 77.17 | 92.56 | 94.67 | 47.39 |
Minority Interest | 0.02 | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 |
Shareholders' Equity | 62.94 | 64.64 | 77.19 | 92.57 | 94.68 | 47.39 |
Total Liabilities & Equity | 111.36 | 108.23 | 105.81 | 121.63 | 122.02 | 114.41 |
Total Debt | 22.03 | 18.89 | 4.13 | 2.47 | 4.24 | 26.92 |
Net Cash (Debt) | -19.46 | -16.16 | 1.37 | 23.03 | 21.92 | -15.25 |
Net Cash Growth | - | - | -94.05% | 5.07% | - | - |
Net Cash Per Share | -1.96 | -1.62 | 0.14 | 2.31 | 3.85 | -3.35 |
Book Value | 62.92 | 64.62 | 77.17 | 92.56 | 94.67 | 47.39 |
Book Value Per Share | 6.32 | 6.49 | 7.75 | 9.30 | 16.61 | 10.42 |
Tangible Book Value | -27.6 | -22.69 | -1.3 | 19.86 | 30.75 | -3.19 |
Tangible Book Value Per Share | -2.77 | -2.28 | -0.13 | 1.99 | 5.39 | -0.70 |